The CDC estimates delivery of a record 194 to 198 million doses of influenza vaccine this year. The primary care imperative: vaccinate, vaccinate, vaccinate.
Two new quadrivalent vaccines licensed for adults aged ≥65 years are available this season to help prevent influenza among this traditionally vulnerable population. Along with 7 other vaccines recommended this year, these agents are already in production with a supply of between 194 - 198 million doses projected for delivery for the 2020-2021 US influneza season.
That number tops last season's record by about 20 million.
With COVID-19 enduring and other seasonal respiratory viruses in circulation, reliance is heavy on first-line providers to help administer every single one of those doses. Here, click through a few more facts on the season, the vaccines, and the populations at greatest risk this year.
A Few Flu Facts: CDC: From October 1, 2019, to April 4, 2020: there were 410 000 – 740 000 hospitalizations and 24 000 – 62 000 deaths related to influenza in the US. Influenza vaccine efficacy was 39% overall during the 2019-2020 season.
Advisory Committee on Immunization Practices (ACIP) Says: Everyone aged ≥6 months should receive the current influenza vaccine. For the 2020-2021 flu season, providers may choose to administer any licensed, age-appropriate flu vaccine (IIV, RIV4, or LAIV4) with no preference for one vaccine over another.
Ensure the Most Vulnerable are Vaccinated. Essential workers,other critical infrastructure workforce; persons at increased risk for severe illness from COVID-19: all persons with certain underlying medical conditions; persons at increased risk for serious influenza complications.
Also at Significant Risk. Members of certain racial/ethnic minority groupsalso are more likely to experiencesevere illness from COVID-19.
Flu Vaccine Options 2020-2021. Standard dose flu shots, high-dose shots for people aged ≥65 years, shots made with adjuvant for people aged ≥65 years, shots made with virus grown in cell culture (no eggs used), recombinant vaccines, live attenuated influenza vaccine (LAIV; nasal spray)
Two New Vaccines Licensed. Quadrivalent high-dose vaccine licensed for use in adults aged ≥65 years; replaces the previously licensed trivalent high-dose vaccine; and, a quadrivalent adjuvanted vaccine licensed for use in adults aged ≥65 years.
All 2020-2021 ACIP-approved vaccines, at-a-glance.
Vaccine Supply Notes 2020-2021. Manufacturers project supplying between 194 - 198 million doses for 2020-2021 – a record number (~20 million more doses than last season’s record 175 million).
More Notes on Supply. Influenza vaccine shipments have begun and will continue throughout August, September, October, and November until all of the vaccine is distributed.
Differentiating Between Influenza and COVID-19. Symptoms, transmission, cause, vaccine.